IP Library Granted Patent US 11,857,529
Granted Patent B2
US 11,857,529 · App. 17/021,733 · Granted Jan 2, 2024

Methods for treating melanoma

Inventors: Carlo Marchetti (Denver, CO); Charles A. Dinarello (Boulder, CO)
Assignee: OLATEC THERAPEUTICS, INC.
A61K31/275A61P35/00C07K16/2818A61K9/0053
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,857,529
App. No.
17/021,733
Granted
Jan 2, 2024
Kind
B2
Abstract

The present invention is directed to a method for preventing and/or treating melanoma such as superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma, and acral lentiginous melanoma. The method comprises administering to a subject in need thereof an effective amount of dapansutrile. The method optionally comprising co-administering anti-PD-1 antibody with dapansutrile. A preferred route of administration is oral administration.

Claims (7)

1. A method of treating melanoma in a subject, comprising the step of:

administering to the subject suffering from the melanoma an effective amount of dapansutrile, or a pharmaceutically acceptable solvate thereof.

2. The method according to claim 1 , wherein the melanoma is selected from the group consisting of: superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma, and acral lentiginous melanoma.

3. The method according to claim 1 , wherein dapansutrile is administered by systemic administration.

4. The method according to claim 3 , wherein the dapansutrile is administered by oral administration.

5. The method according to claim 1 , where the method treats melanoma by reducing the size of melanoma.

6. The method according to claim 1 , further comprising administering anti-PD-1 antibody to the subject.

Assignments (2)
CHANGE OF NAME Recorded Nov 7, 2023
From: OLATEC THERAPEUTICS LLC
To: OLATEC THERAPEUTICS, INC.
Reel/Frame 065489/0809 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2020
From: MARCHETTI, CARLO; DINARELLO, CHARLES A.
To: OLATEC THERAPEUTICS LLC
Reel/Frame 053778/0695 →
Continuity (3)
Continuation PCTUS2019022770 · Mar 18, 2019
Provisional Application 62645999 · Mar 21, 2018
Related Publication 20200405681A1 · Dec 31, 2020